How many insider declarations has Murali Ramachandran filed?

Murali Ramachandran has filed 3 public insider declarations with SEC (Form 4).

What is Murali Ramachandran's role?

Murali Ramachandran's reported role is not specified by the regulator across the filings.

Which companies does Murali Ramachandran report trades for?

Murali Ramachandran reports trades for Kairos Pharma, LTD..

What is Murali Ramachandran's declared buy vs sell volume?

Across the available history, declared buys total 303€ and disposals 0.

← Executives ★ Sign in to follow

MR

Murali Ramachandran

OFFICER

·SEC (Form 4)

Kairos Pharma, LTD.

0

申报总数

0

公司

€303

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the detailed record of transactions filed by Murali Ramachandran. Officer active across 1 company, notably Kairos Pharma, LTD.. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €303. Activity tracked since 25 November 2024. The latest transaction was filed on 8 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Murali Ramachandran

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kairos Pharma, LTD. (US)

申报3 总计

◆

Murali Ramachandran

VP of Research and Development高管2025年10月8日Kairos Pharma, LTD.

0SEC ↗

152,672 股0COMMON STOCKSEC:0001493152-25-025224:0

◆

Murali Ramachandran

VP of Research and Development高管2025年1月1日Kairos Pharma, LTD.

0SEC ↗

14,000 股0COMMON STOCKSEC:0001493152-25-008106:0

▲

Murali Ramachandran

VP of Research and Development高管2024年11月25日Kairos Pharma, LTD.

US$31838SEC ↗

200 股@ US$1.59100.0% 占其流量COMMON STOCKSEC:0001493152-24-047695:0

标准退出：2025年2月23日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MR

Murali Ramachandran

OFFICER

·SEC (Form 4)

Kairos Pharma, LTD.

0

申报总数

0

公司

€303

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the detailed record of transactions filed by Murali Ramachandran. Officer active across 1 company, notably Kairos Pharma, LTD.. In total, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €303. Activity tracked since 25 November 2024. The latest transaction was filed on 8 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.